Skip to main content

Advertisement

Table 2 Characteristics of the included patients

From: Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)

CharacteristicMean (sd) or n (%)
Age67.5 (7.4)
Female sex16 (76.2%)
Comorbidities
 Cardiovascular disease1 (4.8%)
 Osteoporosis4 (19.1%)
 Anxiety/depression3 (14.3%)
 Diabetes2 (9.5%)
 FEV11.76 (0.60)
 FEV1% predicted78.7% (21.7)
 FVC2.74 (0.87)
Bronchiectasis severity index
 Mild4 (19.0%)
 Moderate10 (47.6%)
 Severe7 (33.3%)
 Prior exacerbations3.3 (2.0)
Treatment
 Inhaled corticosteroids11 (52.4%)
 Macrolides12 (57.1%)
 Inhaled antibiotics1 (4.8%)
Baseline quality of life and functional status
 6 min walk distance439 (104)
 CAT score19.1 (6.1)
 SGRQ41.5 (17.0)